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Abstract
: Sub-Saharan Africa faces region-specific risk factors forBackground
chronic kidney disease (CKD), such as nephrotoxic herbal medicines,
antiretroviral therapy and infections, in addition to hypertension and
diabetes. However, large epidemiological studies from this area are scarce.
: In a cross-sectional survey of non-communicable diseases, weMethods
conducted a prevalence sub-study of CKD in two Malawian populations.
Study participants (N=5264) of 18 years of age and above were recruited
and data on demographics and CKD risk factors were collected. Glomerular
filtration rate was estimated (eGFR) using the CKD-EPI equation.
: The prevalence of eGFR<60ml/min/1.73m  was 1.4% (95% CI 1.1Results
– 1.7%) and eGFR<90ml/min/1.73m  was 20.6% (95% CI 19.5 – 21.7%).
The rural area had higher age-standardized prevalence of both
eGFR<60ml/min/1.73m , at 1.8% (95% CI 1.4 – 2.3) and eGFR <90
ml/min/1.73m², at 21.1% (95% CI 19.9 – 22.3), than urban location, which
had a prevalence of 1.5%, (95% CI 1.0 – 2.2) and 19.4% (95% CI 18.0 –
20.8), respectively, with overlapping confidence intervals. The prevalence
of CKD was lower in females than in males in both rural and urban areas.
Older age (p < 0.001), a higher level of education (p = 0.03) and
hypertension (p < 0.001) were associated with a higher adjusted odds ratio
(aOR) of low eGFR. Diabetes was associated with a reduced aOR of
eGFR<90ml/min/1.73m  of 0.69 (95% CI 0.49–0.96; p=0.03). Of
participants with eGFR<60ml/min/1.73m , 14 (19.4%) had no history of
hypertension, diabetes or HIV, while 36 (50%) had a single risk factor of
being hypertensive.
: Impaired renal function is prevalent, but lower thanConclusions
expected, in rural and urban Malawi. Further research is needed to increase
understanding of CKD incidence, survival and validation of eGFR
calculations in this population.
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Introduction
Since 1990, the number of deaths from chronic kidney 
disease (CKD) has risen by 82%, representing the third largest 
increase in deaths, behind HIV/AIDS and diabetes1,2. CKD, 
described as abnormalities of kidney structure or function 
present for longer than three months, is increasingly being 
recognized as an emerging public health problem globally and a 
key determinant of poor health outcomes of millions of people3–5. 
Sub-Saharan Africa (sSA) faces region-specific risk factors 
for CKD, such as nephrotoxic herbal medicines, antiretro-
viral therapy and infections, in addition to hypertension and 
diabetes6,7. The few epidemiological studies in sSA show a large 
variation of CKD prevalence, ranging from 1.5% to 33.5%8.
However, current knowledge about the prevalence of CKD 
and renal disease in Malawi, as in most sSA countries, is 
scarce9. Published data on CKD have been based on opportun-
istic sampling, involving people seeking medical care, or of 
urban populations, who have a different epidemiological profile 
from the rural majority6,10. It is thought that glomerulonephri-
tis and CKD of unknown origin (CKDu), might account for a 
larger proportion of the total CKD burden in rural or disadvan-
taged populations, whilst hypertension and diabetes are more 
prevalent in urban areas3,11.
The absence of community-based representative data on CKD 
is concerning, as strategies aimed at managing CKD in Africa 
critically depend on reliable assessment of the burden of the 
problem and the establishment of affordable early detection 
programs12. As such, we conducted a cross-sectional survey to 
estimate and compare the prevalence of CKD in rural and urban 
Malawi and analyzed the factors associated with this condition.
Methods
Study setting
Participants were selected from a large cross-sectional popu-
lation-based survey, designed to elucidate the burden and 
risk factors of non-communicable diseases in urban and rural 
Malawi13,14. The survey was conducted in a rural area with a 
population of 40,000 people within southern Karonga District 
and Area 25 in Lilongwe, the capital city (Figure 1). Karonga is a 
lakeshore district, with a subsistence economy. Area 25 is an 
economically mixed urban economy with a population of 
around 66,000 individuals. Recruitment and data collection 
took place between May 16th 2013 to February 8th 2016.
Recruitment and data collection
Detailed study procedures of the survey and characteristics of 
the two populations have been previously described13 and all 
consenting adults age 18 years and over, residing within the 
defined study areas, were eligible to participate.
Briefly, the participants were visited in their homes. Writ-
ten informed consent was obtained from all participants for 
interviewer-led questionnaires, documenting the participant’s 
socio-demographic information, lifestyle (e.g. smoking, alcohol, 
diet and physical activity), personal and family health history 
(e.g. hypertension, diabetes, heart disease and HIV) and 
current medications. Anthropometric measurements, measured 
twice by two study staff independently, and three seated blood 
pressure measurements, with 5 minute rests in between, were 
taken, adhering to standard protocols. A rapid HIV test was 
conducted, and results were given to the participants.
Blood was collected from an antecubital vein (following an 
overnight fast of at least 8h) in sodium fluoride tubes and 
plain serum tubes for fasting blood glucose (FBG) and serum 
creatinine tests, respectively. The samples were transported 
on the same day to the onsite project laboratory for the glucose 
assay and the serum was stored for creatinine analysis (mean time 
between collection and processing of 2.6h). We used the hex-
okinase glucose-6-phosphate dehydrogenase method using the 
AU480 Chemistry Analyzer (Beckman Coulter, California, USA), 
with sufficient sensitivity (range 0.555–44.4 mol/L) to determine 
glucose concentrations in the study samples.
Serum separation was done on a Sigma 6–16 centrifuge at 
3000 RPM for 10 minutes. The separated serum was frozen in -
80 freezer in 1.8ml Sarstedt tubes. On the day of analysis, the 
serum samples were taken out of the freezer, allowed to thaw at 
room temperature and then analysed on an AU480 analyser with 
ISE. Kinetic Jaffe (compensated) method, traceable to the isotope 
dilution mass spectrometry (IDMS) reference method was used. 
The AU480 analyser automatically computed the creatinine 
concentration of each sample and interference from protein 
was mathematically auto-corrected by the analyser by sub-
tracting 18 μmol/L from each test result. The instrument was 
equipped with reagent OSR6178, System Calibrator Cat. No. 
66300 traceable to the IDMS method via National Institute of 
Figure 1. Map of Malawi Showing location rural Karonga and 
urban Lilongwe.
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Standards and Technology (NIST) Standard Reference Material 
(SRM) 967 and quality control material, all manufactured by 
Beckman Coulter (California, USA).
Participant ages were grouped into 10-year categories and 
education was categorized by the highest educational level 
achieved (no formal education, completed primary school 
standard 1–5, primary school standard 6–8, secondary, or ter-
tiary). Occupation statuses were grouped into the following 
categories: not working, housework, farming or fishing, employed 
or self-employed. Household wealth scores were determined, 
based on the value of household assets, and then grouped into 
fifths across the total survey population. Physical activity was 
determined by self-reporting of the average duration (minutes) 
and intensity of exercise (pre-coded activities, grouped into 
high exertion, low exertion, or sedentary) in the previous week 
(both at work and during leisure time), used to establish whether 
participants met the World Health Organization (WHO) recom-
mended level of activity per week. Alcohol consumption was 
divided into those who had consumed at least one alcoholic 
drink within the past 12 months and those who had not. Smoking 
status was divided into current smokers, ex-smokers and 
never-smokers.
Body mass index (BMI) categories were <18kg/m2 (underweight), 
18–24.99 kg/m2 (healthy weight), 25–29.99 kg/m2 (overweight) 
and >30 kg/m2 (obese), in line with World Health Organization 
recommendations. Hypertension was defined as one or more 
of: systolic blood pressure of 140mmHg or more; diasto-
lic blood pressure of 90 mmHg or more; and any use of 
antihypertensive medication in the past two weeks. Diabetes was 
defined as fasting plasma glucose of at least 7.0 mmol/L or any 
self-reported prior diagnosis of diabetes, regardless of whether the 
participant was taking anti-diabetic medication.
Sampling participants for serum creatinine measurements
Serum samples were available for 24,780 participants; we sam-
pled 5,264 serum samples for creatinine testing. With this sample 
size, we were able to determine a 0.1 standard difference, with 
power of 80% and p value of 0.01. Our sample was stratified by 
age (18–29, 30–39, 40–49, 50+), sex and site. We over-sampled 
older (aged 40 years plus) age groups in order to increase the 
numbers of individuals with impaired renal function to facilitate 
further analyses and prioritized participants recruited later in 
the study over those recruited earlier. Specifically, we tested 
100 of each age/sex/site combination group for both 2015 and 
2014, the remaining samples coming from participants aged 
40 and older from 2015.
Method of calculating of eGFR
We used the CKD-EPI equation to calculate eGFR:
eGFR = 141 × min(SCr/K, 1)α × max(SCr/K, 1)-1.209 × 0.993Age × 
1.018[if female]
Where SCr is serum creatinine in μmol/L; K is 61.9 for females 
and 79.6 for males; α is -0.329 for females and -0.411 for males; 
Min indicates the minimum of SCr/K or 1, and max indicates 
the maximum of SCr/L or 1.
Using the this equation, not correcting for race, renal func-
tion was categorized as: eGFR <60 ml/min/1.73 m2 (very low 
eGFR, representing CKD), <90 ml/min/1.73 m2 (low GFR) and 
≥90 ml/min/1.73 m2 (normal), based on the National Kidney 
Foundation guidelines.
Statistical analyses
We calculated the age-specific prevalence of eGFR<60ml/
min/1.73m2 and eGFR<90ml/min/1.73m2 according to rural or 
urban residency and sex and estimated population prevalence, 
weighted to represent the age distribution of the underlying 
study population, using age groups of 18–29, 30–39, 40–49, and 
50+, in line with the strategy used for sampling for the creati-
nine assay. In addition, the age-standardized prevalence (to the 
INDEPTH Standard population distribution 2000 – 200515) was 
estimated.
We conducted multivariable logistic regression to exam-
ine the association of different exposures with having an 
eGFR<90ml/min/1.73m2. Exposures were considered in a con-
ceptual framework of distal exposures (age, sex, urban or rural 
study site, education, occupation and household wealth score), 
behavioral exposures (smoking, alcohol consumption and physical 
activity) and pathological exposures (obesity, hypertension and 
impaired fasting glucose), displayed in Figure 2. We report 
the odds ratios (ORs) with 95% confidence intervals (CIs) for 
each of these exposures, adjusted for age and sex only, for 
distal exposures only, and for both distal and behavioral expo-
sures. Complete case analysis was used as a strategy to deal with 
missing data. All analysis was done using Stata version 15.0 
(StataCorp, College Station, TX).
Ethical statement
All participants gave written consent to participate. Ethical 
approval was obtained from Malawi National Health Sciences 
Research Committee protocol number #1072, and London School 
of Hygiene and Tropical Medicine (UK) Ethics Committee 
protocol number #6303.
Results
Participant demographic characteristics
The creatinine assay was conducted on serum from 5264 par-
ticipants. BMI was missing for 123 participants, mainly as it 
was not calculated in pregnant women. Blood pressure and 
diabetes data were missing for 3 and 2 participants, respectively. 
HIV status was not available for 1382 participants.
Socio-demographic characteristics of the participants are 
described in Table 1. 55.2% were from the rural area, 27.6% 
were between age 18 to 29, and 43.4% were farmers or fisher-
men. The rural sample was generally poorer, less well educated, 
and most participants were farmers or fishermen. The urban sample 
comprised more overweight or obese participants and had a 
higher prevalence of hypertension and diabetes.
Crude and age-specific prevalence
The prevalence of eGFR<60ml/min/1.73m2 in our sample 
overall was 1.4% (95% CI 1.1 – 1.7) and the prevalence of 
eGFR<90ml/min/1.73m2 was 20.6% (95% CI 19.5 – 21.7). This is 
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Table 1. Baseline characteristics of the stratified sample by urban and rural study site.
Rural Urban
Female Male Female Male
n (%) n (%) n (%) n (%)
Age
18–29 388 (24.5) 318 (24.3) 447 (32.2) 302 (31.2)
30–39 327 (20.7) 304 (21.7) 329 (23.7) 222 (22.9)
40–49 367 (23.2) 316 (23.5) 328 (23.6) 222 (22.9)
50–59 255 (16.1) 190 (15.3) 177 (12.7) 111 (11.5)
60–69 152 (9.6) 92 (8.4) 74 (5.3) 80 (8.3)
70+ 92 (5.8) 105 (6.8) 34 (2.5) 32 (3.3)
Household possession score
1 (poorest) 419 (26.5) 319 (24.1) 126 (9.1) 99 (10.2)
2 450 (28.5) 380 (28.7) 121 (8.7) 118 (12.2)
3 297 (18.8) 258 (19.5) 253 (18.2) 175 (18.1)
4 332 (21.0) 291 (22.0) 416 (30.0) 234 (24.2)
5 (wealthiest) 83 (5.3) 77 (5.8) 473 (34.1) 343 (35.4)
Occupation
Farming/fishing 1297 (82.0) 966 (72.9) 14 (1.0) 6 (0.6)
Self-employed 113 (7.2) 126 (9.6) 308 (22.2) 245 (25.3)
Employed 30 (1.9) 93 (7.0) 178 (12.8) 378 (39.0)
Not working 63 (4.0) 135 (10.2) 283 (20.4) 271 (28.0)
Housework 78 (4.9) 5 (0.4) 606 (43.6) 69 (7.1)
Figure 2. Conceptual framework of exposures potentially contributing to low estimated glomerular filtration rate (eGFR).
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shown by age and urban or rural location in Table 2 and Table 3 
and Figure 3 and Figure 4. The rural area had higher prevalence 
of both eGFR<60ml/min/1.73m2, at 1.8% (95% CI 1.4 – 2.3), 
and eGFR<90ml/min/1.73m2, at 21.1% (95% CI 19.9 – 22.3), 
than the urban location, which had a prevalence of 1.5% (95% 
CI 1.0 – 2.2) and 19.4% (95% CI 18.0 – 20.8), respectively, 
although with overlapping confidence intervals when standard-
ized to the INDEPTH standard age distribution. The prevalence 
of eGFR<60ml/min/1.73m2 was also slightly lower in females 
than in males in both rural and urban areas.
Exposures associated with low eGFR
Low eGFR was strongly associated with increasing age 
(Table 4), with participants in the over-70 age group having 
148 times the odds of low eGFR than those in the 18–39 age 
group, when adjusted for distal and behavioral exposures 
Rural Urban
Female Male Female Male
n (%) n (%) n (%) n (%)
Education
No formal 145 (9.2) 30 (2.3) 115 (8.3) 24 (2.5)
Standard 1–5 337 (21.3) 169 (12.8) 154 (11.1) 52 (5.4)
Standard 6–8 843 (53.3) 636 (48.0) 345 (24.8) 199 (20.5)
Secondary 243 (15.4) 459 (34.6) 602 (43.3) 474 (48.9)
Tertiary 13 (0.8) 31 (2.3) 173 (12.5) 220 (22.7)
Alcohol consumption
No alcohol in past year 1509 (95.5) 787 (59.4) 1319 (95.0) 635 (65.5)
Alcohol in past year 72 (4.6) 538 (40.6) 70 (5.0) 334 (34.5)
Smoking
Never smoked 1581 (100) 1071 (80.8) 1380 (99.4) 788 (81.3)
Ex-smoker 0 (0) 65 (4.9) 6 (0.4) 88 (9.1)
Current smoker 0 (0) 189 (14.3) 3 (0.2) 93 (9.6)
Physical activity level
Did not meet WHO recommendations 26 (1.6) 36 (2.7) 31 (2.2) 50 (5.2)
Met WHO recommendations 1555 (98.4) 1289 (97.3) 1358 (97.8) 919 (94.8)
Body Mass Index (kg/m2)1
<18 75 (5.0) 80 (6.1) 36 (2.7) 36 (3.7)
18–24.99 1029 (68.1) 1110 (83.9) 598 (44.7) 679 (70.1)
25–29.99 290 (19.2) 118 (8.9) 370 (27.7) 196 (20.2)
30+ 118 (7.8) 15 (1.1) 333 (24.9) 58 (6.0)
Hypertension
Hypertension 262 (16.6) 195 (14.7) 305 (22.0) 217 (22.4)
No hypertension 1317 (83.4) 1129 (85.3) 1084 (78.0) 752 (77.6)
Diabetes
Diabetes 56 (3.5) 50 (3.8) 74 (5.3) 53 (5.5)
No diabetes 1525 (96.5) 1275 (96.2) 1314 (94.6) 915 (94.4)
HIV status
HIV positive 140 (14.3) 101 (13.7) 140 (10.7) 72 (8.4)
HIV negative 840 (85.7) 638 (86.3) 1162 (89.3) 789 (91.6)
1Missing data on 123 participants (69 rural women, 2 rural men, 52 urban women).
2Missing data on 3 participants (2 rural women, 1 rural man).
3Missing data on 2 participants (1 urban woman, 1 urban man).
4Missing data on 1382 participants (601 rural women, 586 rural men, 87 urban women, 108 urban men).
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Table 2. Prevalence (%) of chronic kidney disease (CKD) (eGFR<60 ml/min/1.73m2).
Prevalence Rural Urban
Female Male Total Female Male Total
27/1581 23/ 1325 50/ 2906 10/ 1389 12/ 969 22/ 2358
Stratified study population 1.7 
(1.2-2.5)
1.7 
(1.2-2.6)
1.7 
(1.3-2.3)
0.7 
(0.4-1.3)
1.2 
(0.7-2.2)
0.9 
(0.6-1.4)
Standardized to age distribution of underlying population 1.3 
(0.9-1.9)
1.3 
(0.9-1.9)
1.4 
(1.0-1.8)
0.4 
(0.2-0.7)
0.7 
(0.4-1.2)
0.6 
(0.4-0.8)
Standardized to INDEPTH standard age distribution 1.5 
(1.1-2.1)
1.8 
(1.2-2.6)
1.8 
(1.4-2.3)
1.0 
(0.5-0.2)
1.6 
(1.0-2.7)
1.5 
(1.0-2.2)
Figure 3. Age specific prevalence of low estimated glomerular 
filtration rate (eGFR) in the rural site.
Table 3. Prevalence (%) of low estimated glomerular filtration rate (eGFR<90 ml/min/1.73m2).
Prevalence Rural Urban
Female Male Total Female Male Total
399/ 1581 291/ 1325 690/ 2906 213/ 1389 180/ 969 393/ 1965
Stratified study population 25.24 
(23.2-27.4)
21.96 
(19.8-24.3)
23.7 
(22.2-25.3)
15.3 
(13.5-17.3)
18.6 
(16.3-21.2)
16.7 
(15.2-18.2)
Standardized to age distribution of underlying 
population
19.9 
(18.4-21.5)
18.0 
(16.4-19.7)
19.1 
(18.0-20.3)
10.6 
(9.4-12.0)
12.4 
(10.7-14.3)
11.3 
(10.3-12.5)
Standardized to INDEPTH standard age 
distribution
22.2 
(20.1-23.9)
19.5 
(17.8-21.4)
21.1 
(19.9-22.3)
18.7 
(16.9-21.6)
20.2 
(18.1-22.3)
19.4 
(18.0-20.8)
Figure 4. Age-specific prevalence of low estimated glomerular 
filtration rate (eGFR) in the urban study site.
(95% CI 90.88 – 242.27). Other exposures associated with low 
eGFR in the fully-adjusted model were having a higher educa-
tion level (p=0.03), being a farmer or fisherman, and hypertension 
(p<0.001). Being underweight was associated with reduced odds 
of low eGFR (p=0.03). In our sample, diabetes was associated 
with a reduced adjusted odds ratio (aOR) of eGFR<90ml/min/
1.73m2, with an aOR of 0.57 (95% CI 0.40 – 0.81; p=0.001), 
adjusting for distal and behavioral exposures. Place of resi-
dence was associated with eGFR<90ml/min/1.73m2 with an 
age- and sex-adjusted OR of 0.84 (95% CI 0.72 – 0.98; p=0.03) 
Page 7 of 12
Wellcome Open Research 2019, 4:92 Last updated: 18 JUN 2019
Table 4. Factors associated with estimated glomerular filtration rate (eGFR) <90 adjusted for age and sex only, adjusted for 
distal factors, and adjusted for both distal and behavioral factors.
Adjusted for age and sex only Adjusted for distal factors 
(age, sex, site, education, 
occupation, wealth score)
Adjusted for distal and behavioral 
factors (age, sex, site, occupation, 
wealth score, smoking, alcohol 
and physical activity), and 
diabetes and hypertension
OR (95% CI) p1 OR (95% CI) p1 OR (95% CI) p1
Sex
Female 1
0.26
1
0.02
1
0.39
Male 0.91 (0.78-1.07)
0.81 
(0.68-0.96)
0.92 
(0.76-1.12)
Age group
18–29 1
<0.001
1.00
<0.001
1.00
<0.001
30–39 2.61 (1.87-3.66)
2.59 
(1.83-3.66)
2.50 
(1.77-3.54)
40–49 6.77 (4.99-9.19)
6.68 
(4.86-9.18)
6.27 
(4.55-8.64)
50–59 12.86 (9.41-17.57)
12.98 
(9.37-18.00)
11.32 
(8.09-15.83)
60–69 24.71 (17.67-34.56)
26.01 
(18.37-36.83)
20.69 
(14.35-29.83)
70+ 176.55 (112.37-277.37)
199.27 
(124.15-319.84)
148.38 
(90.88-242.27)
Site
Rural 1
0.03
1
0.92
1
0.82
Urban 0.84 (0.72-0.98)
1.01 
(0.77-1.34)
0.97 
(0.73-1.28)
Household wealth score
1 (poorest) 1
0.53*
1.00
0.54*
1.00
0.78*
2 1.12 (0.87-1.44)
1.12 
(0.87-1.44)
1.10 
(0.85-1.42)
3 1 .00 (0.77-1.29)
1.03 
(0.79-1.35)
1.00 
(0.76-1.31)
4 1.06 (0.83-1.35)
1.06 
(0.83-1.37)
1.02 
(0.79-1.32)
5 (wealthiest) 1.14 (0.88-1.48)
1.15 
(0.86-1.54)
1.11 
(0.82-1.49)
Education
No formal 0.82 (0.60-1.11)
0.03*
0.86 
(0.63-1.19)
0.03*
0.85 
(0.62-1.17)
0.03*
Standard 1–5 0.88 (0.69-1.11)
0.87 
(0.69-1.11)
0.90 
(0.71-1.14)
Standard 6–8 1.00 1.00 1.00
Secondary 0.92 (0.75-1.12)
1.01 
(0.81-1.24)
1.01 
(0.82-1.26)
Tertiary 1.42 (1.07-1.90)
1.47 
(1.04-2.07)
1.53 
(1.08-2.17)
Occupation
Not working 1.25 (0.89-1.76)
<0.001
1.17 
(0.83-1.66)
0.003
1.09 
(0.77-1.56)
0.003
Housework 0.86 (0.63-1.18)
0.89 
(0.65-1.23)
0.87 
(0.63-1.20)
Farming/fishing 1.44 (1.13-1.84)
1.55 
(1.14-2.12)
1.58 
(1.15-2.15)
Self-employed 1.00 1.00 1.00
Employed 1.58 (1.18-2.13)
1.42 
(1.04-1.93)
1.37 
(1.00-1.88)
Page 8 of 12
Wellcome Open Research 2019, 4:92 Last updated: 18 JUN 2019
Adjusted for age and sex only Adjusted for distal factors 
(age, sex, site, education, 
occupation, wealth score)
Adjusted for distal and behavioral 
factors (age, sex, site, occupation, 
wealth score, smoking, alcohol 
and physical activity), and 
diabetes and hypertension
Smoking status
Never smoker 1
0.02
1
0.03
1
0.17Ex-smoker or current 
smoker
0.70 
(0.52-0.94)
0.71 
(0.53-0.97)
0.80 
(0.59-1.10)
Alcohol consumption
Never 1
0.06
1
0.05
1
0.11
Rarely/often 0.81 (0.65-1.01)
0.80 
(0.64-1.00)
0.83 
(0.65-1.04)
Physical activity2
Did not meet WHO 
recommendation
1.48 
(0.96-2.28) 0.08
1.44 
(0.93-2.23) 0.10
1.32 
(0.85-2.07) 0.22
Met WHO recommendation 1.00 1.00 1.00
BMI (kg/m2)3
<18 0.58 (0.38-0.89)
0.03
0.57 
(0.38-0.87)
0.009
0.62 
(0.41-0.94)
0.04
18–24.99 1 1.00 1.00
25–29.99 1.12 (0.92-1.36)
1.19 
(0.97-1.45)
1.16 
(0.94-1.43)
30+ 1.04 (0.82-1.34)
1.13 
(0.87-1.48)
1.04 
(0.79-1.37)
Hypertension4
No hypertension 1
<0.001
1
<0.001
1
<0.001
Hypertension 1.57 (1.30-1.88)
1.69 
(1.40-2.05)
1.77 
(1.46-2.16)
Diabetes5
No diabetes 1
0.03
1
0.03
1
0.001
Diabetes 0.71 (0.51-0.98)
0.70 
(0.50-0.97)
0.57 
(0.40-0.81)
HIV
Negative 1
0.50
1
0.52
1
0.29
Positive 1.09 (0.84-1.41)
1.09 
(0.84-1.42)
1.16 
(0.89-1.51)
1. Likelihood ratio tests for association. Values marked with * are test-for-trend p-values.
2. High defined as meeting recommended WHO physical activity levels.
3. Missing data on 123 participants
4. Defined as blood pressure ≥140/90 or on antihypertensive medication, missing data on 3 participants
5. Defined as fasting plasma glucose≥7.1 or self-report, missing data on 3 participants
BMI, body mass index; OR, odds ratio; CI, confidence intervals
for urban residence, with rural as the reference. The asso-
ciation was no longer seen when also adjusting for distal or 
behavioral exposures.
Of those who had eGFR<60ml/min/1.73m2, 14 (19.4%) had no 
history of hypertension, diabetes or HIV (Table 5). Thirty-six 
(50.0%) of the participants with eGFR<60ml/min/1.73m2 had 
a single risk factor of being hypertensive, eight (11.1%) had a 
single risk factor of HIV and nine (19.4%) had two known risk 
factors of CKD.
Discussion
In this large, population-based, cross-sectional stratified sample, 
we found an overall standardized prevalence of eGFR<90ml/
min/1.73m2 of 20.6% and eGFR<60ml/min/1.73m2 of 1.4% 
using the CKD-EPI equation. A study conducted in Lilongwe 
by Glaser et al. found a prevalence of eGFR<60ml/min/1.73m2 
of 3.1%, in individuals seeking HIV testing in urban Malawi8. 
These estimates are comparable to those found in other regional 
studies and validate a growing body of research indicating 
presence of undiagnosed CKD at population level16,17.
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In our study, low eGFR was associated with occupation (farmers/ 
fisherman more likely to have decreased eGFR), increasing 
age, and hypertension and was inversely associated with being 
underweight in fully adjusted analyses. These associations are 
similar to those found by Kalyesubula et al. in rural Uganda17. 
The high prevalence of CKD amongst rural participants and 
farmers has been documented in other literature18. Rural agri-
cultural communities from Central America, Egypt, India, and 
Sri Lanka have reported a high prevalence of CKDu of unknown 
etiology, and a clinical presentation suggestive of interstitial 
nephritis, confirmed by renal biopsies, with male farm workers 
affected disproportionately3. The rural site investigated in the 
study has a high population of males working in agricultural 
fields in similar circumstances to those studied in other regions 
and we could postulate that it has similar epidemiology, but more 
research is required. Alternately, the result could be confounded 
by higher creatinine levels due to the high muscle mass in this 
physically active group. Similarly, the lower odds of CKD in 
underweight participants may reflect reduced muscle bulk with 
lower creatinine production. As expected, loss of renal func-
tion in our study was associated with an older age. CKD may be 
a consequence of expected age-related renal function decline, 
accelerated in hypertension, diabetes, obesity, and primary renal 
disorders5. Similar studies in other settings have shown that an 
age of over 60, female gender, low educational status, increased 
waist circumference, hypertension, and diabetes were associ-
ated with low eGFR16. The high prevalence of CKD amongst 
hypertensive participants is in keeping with several similar stud-
ies carried out in sSA1,6. Inadequate blood pressure control may 
explain the prevalence of CKD observed7; however, poor renal 
function may also lead to an increase in blood pressure.
Our study also suggests an inverse association between renal 
impairment and diabetes. A survivor bias in the cross-sectional 
design may explain this association16, as it is possible that 
people with diabetes die before developing renal impairment, 
or that people with diabetes who develop renal impairment 
have very poor survival. Additionally, hyperfiltration is a 
feature of early diabetic nephropathy, associated with a high 
eGFR. Early diabetic kidney disease would not be picked up 
from the eGFR alone, and may bias the results in the direction 
of diabetes being protective for kidney disease19.
The results of the study are useful because of the large sam-
ple size, the study of the general population rather than patients 
in a clinical setting, and the ability to compare between rural and 
urban populations. The previous study conducted in Lilongwe 
recruited participants attending a HIV Testing and Counsel-
ling Centre and may not be a good estimate of population 
prevalence. In particular, the prevalence of HIV in the study 
was greater than in the general population and the HIV-negative 
patients may have been symptomatic for other conditions, 
prompting self-referral for HIV testing9. As our study population 
is of a similar age and sex structure to the Malawian population 
and represent typical rural and urban populations, our results are 
likely to be representative of the rest of the country, and possibly 
to other similar populations in low resource and low income 
countries1.
A limitation of our study was relying on serum creatinine for the 
measurement of CKD with no urine albumin:creatinine ratio, 
since classification of CKD stages one and two includes other 
evidence of renal damage including proteinuria, haematuria, or 
evidence of abnormal anatomy or systemic disease. Further-
more, CKD can only be formally diagnosed if low eGFR and/or 
a high urine albumin:creatinine ratio have been found at two 
different times, with at least a three month gap2, and 30–40% 
of patients labelled as CKD stage 3A when the diagnosis is based 
on only a single eGFR determination move to ‘normal’2. There-
fore, the reported prevalence of CKD might be overestimated7. 
However, as nearly all other prevalence studies have defined CKD 
based on a one-off measurement of eGFR <60 mL/min/1.73m2, 
this does allow our results to be directly comparable to much of 
the published data2,20. Furthermore, the study used CKD-EPI 
Table 5. Number and proportion of participants with known hypertension, diabetes and HIV with low and very low 
estimated glomerular filtration rate (eGFR)1.
eGFR>90 eGFR 60-90 eGFR<60 Total
n (%) n (%) n (%) n (%)
No known risk factors No hypertension, diabetes, or HIV 3259 (88.0%%) 547 (54.1%) 14 (19.4%) 3820 (72.6%)
Single known risk factor Hypertension only 433 (10.4%) 315 (31.2%) 36 (50.0%) 784 (14.9%)
Diabetes only 58 (1.4%) 14 (1.4%) 0 72 (1.4%)
Known HIV only 304 (7.3%) 68 (6.7%) 8 (11.1%) 380 (7.2%)
2 known risk factors Hypertension and diabetes 83 (2.0%) 43 (4.3%) 9 (12.5%) 135 (2.6%)
Hypertension and HIV 25 (0.6%) 17 (1.7%) 5 (6.9%) 47 (0.9%)
Diabetes and HIV 11 (0.3%) 2 (0.2%) 0 13 (0.2%)
3 known risk factors Hypertension, diabetes and HIV 8 (0.2%) 5 (0.5%) 0 13 (0.2%)
Overall 4181 1011 72 5264
1 Participants with missing data on any of the three risk factors examined were classified as not having known risk factor
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equation in the determination of eGFR, which is considered to 
be a more accurate predictor of clinical risk than other serum-
based equations, including the Modification of Diet in Renal 
Disease (MDRD) equation5. However, the CKD-EPI equation 
has not been validated for the African population, so it is possible 
that calculated eGFR is not reflecting the underlying kidney 
function accurately in our population. Finally, cross-sectional 
studies do not allow one to derive a causal inference, which is 
particularly important when considering the relationship between 
hypertension, diabetes and CKD.
Conclusion
Our study is the first to estimate population-level prevalence 
of CKD in urban and rural Malawi, and highlights that there is 
already a substantial burden of disease. With an ageing popula-
tion and increasing prevalence of hypertension, this is likely to 
increase over the coming decades. Furthermore, in the absence 
of screening of high-risk individuals, diagnosis, and appropri-
ate service provision, poor survival with CKD is likely and 
this estimated prevalence may mask a much higher incidence. 
Longitudinal research is urgently needed to increase under-
standing of CKD incidence, survival and validation of eGFR 
calculations in this population.
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